Not Tagged
arcellx
['multiple myeloma', 'cart,(-cartitude)', 'arcellx', '$aclx']
$aclx arcellx presents continued robust long-term responses from its cart-ddbcma phase 1 expansion trial in patients with relapsed or refractory multiple myeloma at the 2022 asco annual meeting stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.